The Capital Link Announces Investigation Into the LuxUrban Story – The $300 Million Hotel Startup That Paid Workers 115% of Their Wages While the City Never Paid Up
San Diego, CA, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The Capital Link is…
SKEMA presents UNVEIL, its 2025 – 2030 strategic plan
To unveil talents and transform societies PARIS, Oct. 9, 2025 /PRNewswire/ --…
UEG Week 2025: Microplastics found to change gut microbiome in first human-sample study
BERLIN, Oct. 7, 2025 /PRNewswire/ -- New research presented today at UEG Week…
Bitget CEO Gracy Chen Supports Inaugural UNICEF Game Jam
VICTORIA, Seychelles, Oct. 3, 2025 /PRNewswire/ -- Bitget, the world's leading Universal…
New Imprivata Report Finds that Australian Hospitals Save More Than $1.2 Million AUD Annually with Shared-Use Mobile Devices, but Strategic Gaps Still Pose Security and Operational Risk
MELBOURNE, Australia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of…
CellPoint Digital Launches One Source Orchestration, the First Payment Optimization Platform to Meet the Demand of OOSD Retailing Models
Built for the new generation of airline and travel retail, OSO turns…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting
September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in…
Growing in Southeast Asia: Messe Frankfurt partners with GIAMM on Automechanika Jakarta debuting in 2026
Jakarta, 17 September 2025. During today’s press conference, Messe Frankfurt announced the…
